TME Pharma (France) Probability of Future Stock Price Finishing Over 17.22

ALTME Stock   0.09  0.01  8.27%   
TME Pharma's future price is the expected price of TME Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of TME Pharma NV performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
  
Please specify TME Pharma's target price for which you would like TME Pharma odds to be computed.

TME Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of TME Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for TME Pharma NV can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
TME Pharma NV generated a negative expected return over the last 90 days
TME Pharma NV has high historical volatility and very poor performance
TME Pharma NV has some characteristics of a very speculative penny stock

TME Pharma Technical Analysis

TME Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. TME Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of TME Pharma NV. In general, you should focus on analyzing TME Stock price patterns and their correlations with different microeconomic environments and drivers.

TME Pharma Predictive Forecast Models

TME Pharma's time-series forecasting models is one of many TME Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary TME Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about TME Pharma NV

Checking the ongoing alerts about TME Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for TME Pharma NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
TME Pharma NV generated a negative expected return over the last 90 days
TME Pharma NV has high historical volatility and very poor performance
TME Pharma NV has some characteristics of a very speculative penny stock

Additional Tools for TME Stock Analysis

When running TME Pharma's price analysis, check to measure TME Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TME Pharma is operating at the current time. Most of TME Pharma's value examination focuses on studying past and present price action to predict the probability of TME Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TME Pharma's price. Additionally, you may evaluate how the addition of TME Pharma to your portfolios can decrease your overall portfolio volatility.